₹ 648.34₹ 648.34
In Amyotrophic lateral sclerosis (ALS) Amyotrophic lateral sclerosis (ALS) is a disease of the nerves that restricts muscle movements and hence affects the physical functions of the affected person. Adradac 1.5mg Injection improves nerve activity and muscle strength. This helps the person to carry out the daily activities like walking, talking, chewing, etc, more conveniently. Hence, the person becomes more confident.
Adradac 1.5mg Injection is used in the treatment of amyotrophic lateral sclerosis (a nervous system disease that weakens the muscles and impairs physical functions). It is an antioxidant that slows down nerve damage and prevents further progression of the disease.Adradac 1.5mg Injection is administered as an injection under the supervision of a healthcare professional and should not be self-administered. It is given in cases where oral administration is not possible. Take this medicine in the dose and duration as advised by your doctor and if you have missed a dose, take it as soon as you remember.The most common side effects of this medicine are headache, bruising, and walking difficulties (gait disturbance).? You may also notice some injection site reactions such as pain, redness, or swelling. However, these are temporary and usually resolve on their own. Please consult your doctor if these do not subside or bother you. You should inform the doctor if you develop any allergic reactions like itching, swelling of the lips, tongue, or face, after taking the medication as these require immediate medical attention.
Edaravone (1.5mg)
Amyotrophic lateral sclerosis (ALS)
Bruise | Walking difficulties | Headache | Injection site reactions (pain, swelling, redness)
CONSULT YOUR DOCTOR
CONSULT YOUR DOCTOR
CONSULT YOUR DOCTOR
CONSULT YOUR DOCTOR
CONSULT YOUR DOCTOR
CAUTION
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Mollitia iste laborum ad impedit pariatur esse optio tempora sint ullam autem deleniti nam in quos qui nemo ipsum numquam.
Add A Review
Your email address will not be published. Required fields are marked
Your Rating *
You need to Login OR Register